Drug Profile
Hepatitis A vaccine live - Biolotus
Latest Information Update: 07 Jul 2015
Price :
$50
*
At a glance
- Originator Biolotus
- Class Attenuated vaccines; Hepatitis A vaccines; Viruses
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Hepatitis A
Most Recent Events
- 07 Jul 2015 Launched for Hepatitis A (In adults, In children, In adolescents) in Brazil (Parenteral)